Watch More Highlights
Sandra Kurtin, PhD, ANP-C, AOCN, of the University of Arizona Cancer Center, discusses the largest reported analysis to date of patients with aggressive B-cell lymphoma who developed progressive disease after CAR T-cell therapy. This is of special interest to advanced practitioners, since there is little guidance on the optimal treatment approaches for these patients (Abstract 884).